 SOMERSET, N.J.--BUSINESS WIRE--Legend Biotech Corporation NASDAQ: LEGN Legend Biotech, a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, announced today that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has accepted a request for an accelerated assessment of the Marketing Authorisation Application MAA for the investigational B-cell ma 